Loading chat...
DE HB386
Bill
Status
8/29/2018
Primary Sponsor
Paul Baumbach
Click for details
AI Summary
-
Requires all individual health insurance policies in Delaware to cover treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute onset neuropsychiatric syndrome (PANS), including intravenous immunoglobulin therapy.
-
Requires all group and blanket health insurance policies in Delaware to cover PANDAS and PANS treatment, including intravenous immunoglobulin therapy.
-
Requires State employee health plans under Title 29 to provide coverage for PANDAS and PANS treatment, including intravenous immunoglobulin therapy.
-
Requires public assistance health benefit plans under Title 31 to provide coverage for PANDAS and PANS treatment, including intravenous immunoglobulin therapy.
-
Suspends coverage requirements for individual and group insurance plans if federal law under the Affordable Care Act requires Delaware to defray the cost of this coverage.
Legislative Description
An Act To Amend Title 18, Title 29, And Title 31 Of The Delaware Code Relating To Coverage For Treatment Of Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections And Pediatric Acute Onset Neuropsychiatric Syndrome.
Last Action
Signed by Governor
8/29/2018